Literature DB >> 4029267

Expression of the 2-5A system during the cell cycle.

V Wells, L Mallucci.   

Abstract

To determine whether the 2-5A system has a role in the regulation of cell growth we have examined all constituents of the 2-5A pathway in mouse embryo fibroblasts undergoing one cycle of division at the tertiary stage under conditions where a high degree of uniformity is maintained within each stage of the cycle. Levels of the 2-5A synthetase increased up to tenfold late in S phase and declined as cells moved through G2. A similar but smaller increase in the 2-5A-dependent ribonuclease was observed, whereas activity of the 2'5' phosphodiesterase was highest in quiescent cells. At the time of maximum synthetase levels no phosphorylated 2-5A could be detected in the intact cell. Endogenous interferon (IFN) was found in the culture supernatants in increasing concentration with cell cycle progression and addition of antibodies to IFN reduced the increase in synthetase seen in late S. Treatment of cells with a growth inhibitor that cells produce also affected synthetase activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4029267     DOI: 10.1016/s0014-4827(85)80034-3

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  13 in total

1.  Regulation of 2',5'-oligoadenylate synthetase gene expression by interferons and platelet-derived growth factor.

Authors:  M A Garcia-Blanco; P Lengyel; E Morrison; C Brownlee; C D Stiles; M Rutherford; G Hannigan; B R Williams
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

2.  Beta and gamma interferons act synergistically to produce an antiviral state in cells resistant to both interferons individually.

Authors:  J A Lewis; A Huq; B Shan
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

3.  Interferon inhibits the accumulation of glycerol phosphate dehydrogenase mRNA in oligodendrocytes and C6 cells.

Authors:  A C Passaquin; G Coupin; W A Schreier; P Poindron; R A Cole; J de Vellis
Journal:  Neurochem Res       Date:  1989-10       Impact factor: 3.996

4.  Signal transduction pathways in the induction of 2',5'-oligoadenylate synthetase gene expression by interferon alpha/beta.

Authors:  C Yan; P B Sehgal; I Tamm
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Chemical synthesis and biological characterization of phosphorothioate analogs of 2', 5'-3'-deoxyadenylate trimer.

Authors:  R W Sobol; R Charubala; W Pfleiderer; R J Suhadolnik
Journal:  Nucleic Acids Res       Date:  1993-05-25       Impact factor: 16.971

6.  Interferon-alpha down-regulates the interleukin-6 receptor in a human multiple myeloma cell line, U266.

Authors:  J C Anthes; Z Zhan; H Gilchrest; R W Egan; M I Siegel; M M Billah
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

7.  Cyclic AMP mediates the direct antiproliferative action of mismatched double-stranded RNA.

Authors:  H R Hubbell; J E Boyer; P Roane; R M Burch
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

8.  Lupus-Associated Functional Polymorphism in PNP Causes Cell Cycle Abnormalities and Interferon Pathway Activation in Human Immune Cells.

Authors:  Yogita Ghodke-Puranik; Jessica M Dorschner; Danielle M Vsetecka; Shreyasee Amin; Ashima Makol; Floranne Ernste; Thomas Osborn; Kevin Moder; Vaidehi Chowdhary; Elias Eliopoulos; Maria I Zervou; George N Goulielmos; Mark A Jensen; Timothy B Niewold
Journal:  Arthritis Rheumatol       Date:  2017-11-09       Impact factor: 10.995

9.  Expression of human HSP70 during the synthetic phase of the cell cycle.

Authors:  K L Milarski; R I Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

10.  Induction and regulation of mRNA encoding 26-kDa protein in human cell lines treated with recombinant human tumor necrosis factor.

Authors:  P Defilippi; P Poupart; J Tavernier; W Fiers; J Content
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.